CSL completes Vifor Pharma acquisition; here’s how shares are faring on ASX

CSL Limited finally completed the Vifor Pharma acquisition on 9 August 2022.

How are CSL shares performing after finalisation of Vifor acquisition?

Shares of CSL Limited (ASX:CSL) gained almost 1% on the ASX today although no price sensitive news came from the company’s camp today.

Here’s why Mesoblast (ASX:MSB) has suspended trading today

Mesoblast shares went under a voluntary suspension on the ASX today. Trading is expected to commence after the company releases its capital raising announcement on 10 August 2022.

CSL, COH, PNV: Take a look at R&D activities of ASX healthcare giants

CSL, COH, TLX, NAN, and PNV are some of the major ASX-listed healthcare firms with strong investment and robust R&D activities.

Why are Mesoblast (ASX:MSB) shares in trading halt today?

Mesoblast Ltd (ASX:MSB) on Thursday said that it would be placing its shares in a trading halt

Up 14% in six months, can CSL shares maintain momentum on ASX?

Shares of CSL are in red today (4 August) following the benchmark performance.

A glimpse into National Disability Insurance Scheme (NDIS)

NDIS provides monetary support and assistance to Australians born with or have acquired a permanent and significant disability.

Monkeypox cases rising in Australia; Will healthcare giants be impacted?

Monkeypox is spreading across the entire world. Australia reported 44 confirmed case till now. The government has declared the situation as a 'national significance' . Lets see how it will impact the ASX healthcare sector.

CSL Limited (ASX:CSL) gains over 16% in six months, here’s why

CSL shares closed in red today probably due to the delay in Vifor acquisition.

Nanosonics (ASX:NAN) expects FY22 revenue to touch AU$120M

Shares of Nanosonics (ASX:NAN) dropped by over 9% today despite sharing that its shipping volume has increased considerably